12:00 AM
Sep 28, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aridol mannitol regulatory update

FDA's Pulmonary-Allergy Drugs Advisory Committee will meet on Nov. 20 to discuss an NDA from Pharmaxis for Aridol mannitol powder inhalation test to assess bronchial hyperresponsiveness (airway...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >